Cadre Holdings earns a Buy rating after a 45% share price decline, supported by record backlog and strong acquisition performance. CDRE's strategy hinges on disciplined M&A in fragmented, mission-critical safety markets, with manageable goodwill levels and robust free cash flow. My 2028 price target is $39, implying 55% upside, though I question the high dividend payout given capital allocation priorities.
The stock dropped below a key technical support level this week.
Cadre NYSE: CDRE reported second-quarter results marked by higher sales, profitability and backlog, citing demand across public safety and nuclear safety markets and contributions from recent acquisitions.
| Aerospace & Defense Industry | Industrials Sector | Warren Kanders CEO | XFRA Exchange | US12763L1052 ISIN |
| US Country | 2,533 Employees | 31 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Cadre Holdings, Inc., founded in 1964 and based in Jacksonville, Florida, stands as a pivotal manufacturer and distributor of safety equipment designed to protect users in hazardous or life-threatening situations across the globe. The company operates through two primary segments: Products and Distribution, catering to a wide array of customers including first responders like law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, as well as federal agencies such as the U.S. Department of Defense, Department of State, and many others. With a rich heritage and a commitment to safety, Cadre Holdings, Inc. delivers an extensive range of protective gear and equipment under renowned brand names like Safariland and Protech Tactical, among others.